This document outlines a benchmarking study on medical affairs organizations within leading pharmaceutical and biotech companies, focusing on their structure, budget allocation, and key functions. Key findings indicate that most medical affairs departments are centralized, report to executive teams, and allocate significant portions of their budget to medical research and education. Despite some economic pressures, a majority of companies have not experienced significant reductions in resources or staffing in their medical affairs departments.
Related topics: